Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Fish and Richardson
UBS
Cantor Fitzgerald
Medtronic
Chinese Patent Office
McKesson
Baxter
Harvard Business School

Generated: August 20, 2018

DrugPatentWatch Database Preview

Apothecon Company Profile

« Back to Dashboard

What is the competitive landscape for APOTHECON, and what generic and branded alternatives to APOTHECON drugs are available?

APOTHECON has one hundred and fourteen approved drugs.

There are three tentative approvals on APOTHECON drugs.

Summary for Apothecon
US Patents:0
Tradenames:77
Ingredients:47
NDAs:114

Drugs and US Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon DICLOXACILLIN SODIUM dicloxacillin sodium FOR SUSPENSION;ORAL 061455-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Apothecon AMIKIN amikacin sulfate INJECTABLE;INJECTION 050495-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Apothecon PENICILLIN G POTASSIUM penicillin g potassium TABLET;ORAL 060392-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Apothecon AMOXICILLIN amoxicillin TABLET, CHEWABLE;ORAL 064131-002 May 6, 1996 DISCN No No ➤ Sign Up ➤ Sign Up
Apothecon CEFADYL cephapirin sodium INJECTABLE;INJECTION 062724-001 Dec 23, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
Apothecon AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER amikacin sulfate INJECTABLE;INJECTION 050618-001 Nov 30, 1987 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon CAPOZIDE 50/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-003 Oct 12, 1984 4,217,347 ➤ Sign Up
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984 4,105,776 ➤ Sign Up
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984 4,217,347 ➤ Sign Up
Apothecon STADOL PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 017857-001 Approved Prior to Jan 1, 1982 3,819,635 ➤ Sign Up
Apothecon CAPOZIDE 50/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-003 Oct 12, 1984 4,105,776 ➤ Sign Up
Apothecon CAPOZIDE 25/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-001 Oct 12, 1984 4,217,347 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
UBS
Julphar
Johnson and Johnson
Moodys
Express Scripts
Medtronic
QuintilesIMS
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.